Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nita A Limdi

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Current Opinion in Molecular Therapeutics|May 30, 2009
Warfarin pharmacogenomicsLarisa H Cavallari, Nita A Limdi
Pharmacotherapy|April 23, 2013
Reversal of oral anticoagulationJonathan L Thigpen, Nita A Limdi
Clinical Pharmacology and Therapeutics|July 7, 2021
Translational Pharmacogenomics: Discovery, Evidence Synthesis and Delivery of Race-Conscious MedicineBrittney H Davis, Nita A Limdi
Pharmacotherapy|August 30, 2008
Warfarin pharmacogeneticsNita A Limdi, David L Veenstra
Journal of Clinical Epidemiology|December 10, 2009
Expectations, validity, and reality in pharmacogeneticsNita A Limdi, David L Veenstra
Pharmacogenomics|October 23, 2018
Pharmacogenetics of warfarin dosing in patients of African and European ancestryAditi Shendre, Chrisly Dillon, Nita A Limdi
Pharmacogenomics|September 11, 2008
Ethnic differences in warfarin maintenance dose requirement and its relationship with geneticsHedi Schelleman, Nita A Limdi, Stephen E Kimmel
Bioinformatics (Oxford, England)|April 1, 2011
High-dimensional pharmacogenetic prediction of a continuous trait using machine learning techniques with application to warfarin dose prediction in African AmericansErdal Cosgun, Nita A Limdi, Christine W Duarte
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Superiority of fixed-dose warfarin for chronic anticoagulationNita A Limdi, Nancy V Lemons, Camilo R Gomez
Cardiology|September 21, 2013
Vitamin K intake, body mass index and warfarin maintenance doseEdmond K Kabagambe, T Mark Beasley, Nita A Limdi
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Current Opinion in Molecular Therapeutics|May 30, 2009
Warfarin pharmacogenomicsLarisa H Cavallari, Nita A Limdi
Pharmacotherapy|April 23, 2013
Reversal of oral anticoagulationJonathan L Thigpen, Nita A Limdi
Clinical Pharmacology and Therapeutics|July 7, 2021
Translational Pharmacogenomics: Discovery, Evidence Synthesis and Delivery of Race-Conscious MedicineBrittney H Davis, Nita A Limdi
Pharmacotherapy|August 30, 2008
Warfarin pharmacogeneticsNita A Limdi, David L Veenstra
Journal of Clinical Epidemiology|December 10, 2009
Expectations, validity, and reality in pharmacogeneticsNita A Limdi, David L Veenstra
Pharmacogenomics|October 23, 2018
Pharmacogenetics of warfarin dosing in patients of African and European ancestryAditi Shendre, Chrisly Dillon, Nita A Limdi
Pharmacogenomics|September 11, 2008
Ethnic differences in warfarin maintenance dose requirement and its relationship with geneticsHedi Schelleman, Nita A Limdi, Stephen E Kimmel
Bioinformatics (Oxford, England)|April 1, 2011
High-dimensional pharmacogenetic prediction of a continuous trait using machine learning techniques with application to warfarin dose prediction in African AmericansErdal Cosgun, Nita A Limdi, Christine W Duarte
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Superiority of fixed-dose warfarin for chronic anticoagulationNita A Limdi, Nancy V Lemons, Camilo R Gomez
Cardiology|September 21, 2013
Vitamin K intake, body mass index and warfarin maintenance doseEdmond K Kabagambe, T Mark Beasley, Nita A Limdi
Pageof 12